Neutralising antibodies in patients with multiple myeloma receiving maintenance therapy with interferon α2b

Leukocyte Interferon-Induced Tumor Regression in Human Metastatic Breast Cancer, Multiple Myeloma, and Malignant Lymphoma

1980 • 503 citations

Resistance to Recombinant Interferon Alfa-2a in Hairy-Cell Leukemia Associated with Neutralizing Anti-Interferon Antibodies

1988 • 251 citations

Cognitive features of continuous antigenic determinants

1988 • 162 citations

Intensive combined therapy for previously untreated aggressive myeloma

1992 • 151 citations

Interactions of human leukocyte interferon with vinca alkaloids and other chemotherapeutic agents against human tumors in clonogenic assay

1983 • 147 citations

Incidence and clinical significance of neutralizing antibodies in patients receiving recombinant interferon alfa-2a by intramuscular injection

1987 • 121 citations

Phase II study of recombinant alpha-2 interferon in resistant multiple myeloma.

1985 • 108 citations

Recombinant human interferon (IFN) alpha‐2b in chronic myelogenous leukaemia: dose dependency of response and frequency of neutralizing anti‐interferon antibodies

1989 • 108 citations

Natural interferon-alpha in combination with melphalan/prednisone versus melphalan/prednisone in the treatment of multiple myeloma stages II and III: a randomized study from the Myeloma Group of Central Sweden

1993 • 105 citations

ANTIBODIES TO HUMAN LEUCOCYTE INTERFERONS IN CANCER PATIENTS

1983 • 103 citations

Low incidence of serum neutralizing factors in patients receiving recombinant alfa-2b interferon (intron a)

1986 • 102 citations

Autoantibodies to crude human leucocyte interferon (IFN), native human IFN, recombinant human IFN-alpha 2b and human IFN-gamma in healthy blood donors

1990 • 100 citations

Multiple myeloma: circulating lymphocytes that express plasma cell antigens

1984 • 98 citations

Alfa-2b interferon in the treatment of Hodgkin's disease and non-Hodgkin's lymphoma.

1987 • 71 citations

Anti-interferon antibodies: a perspective.

1988 • 61 citations

Assessment of the antigenic response in humans to a recombinant mutant interferon beta

1987 • 47 citations

Loss of interferon antibodies during prolonged continuous interferon-alpha 2a therapy in hairy cell leukemia.

1991 • 45 citations

Interferon Therapy in Multiple Myeloma

1979 • 45 citations

Interferon alfa-2b with VMCP compared to VMCP alone for induction and interferon alfa-2b compared to controls for remission maintenance in multiple myeloma: Interim results

1991 • 27 citations

A simple method for culturing myeloma cells from human bone marrow aspirates and peripheral blood in vitro

1988 • 25 citations

Treatment of multiple myeloma with interferon alpha: the Scandinavian experience

1991 • 24 citations

Interferon therapy during the plateau phase of multiple myeloma: An update of the Swedish study

1991 • 15 citations

alpha-Interferon for remission maintenance: preliminary report on the Southwest Oncology Group Study.

1991 • 15 citations

Treatment with natural human interferon alpha of a CML-patient with antibodies to recombinant interferon alpha-2 b

1988 • 13 citations

Low incidence of antibody formation due to long-term interferon-?2c treatment of cancer patients

1992 • 11 citations

Multiple myeloma: Intensified maintenance therapy with recombinant interferon‐α‐2b plus glucocorticoids

1992 • 11 citations

Cognitive features of continuous antigenic determinants

1989 • 7 citations

Effect of interferon alpha‐2b in advanced multiple myeloma

1990 • 5 citations

[Clinical trial of alpha-interferon (human lymphoblastoid interferon) in combination with VCAP chemotherapy in multiple myeloma].

1991 • 1 citations